Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03585712 · ClinicalTrials.gov registry record · Phase 2

Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill

A Phase 2 study of Contraception, sponsored by HRA Pharma.

Completed
Registry status
Phase 2
Development phase
52
Enrollment target
2
Study locations

NCT03585712 is a Phase 2 study of Contraception that has completed, run by HRA Pharma. The registered enrollment target is 52 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03585712, a Phase 2 study of Contraception, has completed, sponsored by HRA Pharma.

COMPLETED
Registry status
Phase 2
Development phase
52 participants
Enrollment target
2
Study locations

Study Summary

Norgestrel 75 mcg is a progestin-only pill (POP), which is a kind of oral birth control pill. To be effective in preventing pregnancy, this kind of birth control pill is supposed to be taken every day at the same time, without delaying the intake for more than 3 hours. This study aims to find out if taking the pill 6 hours late or not taking it for one day will affect the way it works.

Conditions Studied

Contraception

Interventions

  • DRUG Norgestrel 0.075 mg

Study Locations (2)

California

  • University of California Davis - Sacramento

Oregon

  • Oregon Health and Sciences University - Portland

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2018-07-24
Est. Completion 2020-04-07
Phase Phase 2

Sponsor

HRA Pharma

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03585712

The ClinicalTrials.gov registry entry for NCT03585712 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (89% lower). The listed sponsor is HRA Pharma, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Norgestrel 0.075 mg is the first listed.

NCT03585712 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Oregon.

Frequently Asked Questions

What is clinical trial NCT03585712 about?

NCT03585712 is a clinical study titled "Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill". Norgestrel 75 mcg is a progestin-only pill (POP), which is a kind of oral birth control pill. To be effective in preventing pregnancy, this kind of birth control pill is supposed to be taken every day at the same time, without delaying the intake for more than 3 hours. This study aims to find out ...

What is the current status of trial NCT03585712?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2018-07-24. Estimated completion is 2020-04-07.

What conditions does trial NCT03585712 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT03585712?

The interventions under investigation include: Norgestrel 0.075 mg (DRUG).

Who is sponsoring clinical trial NCT03585712?

This trial is sponsored by HRA Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03585712 being conducted?

This trial has 2 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Contraception

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.